MAGLi 432 is a non-covalent, potent, highly selective, and reversible MAGL inhibitor. MAGLi 432 binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme). MAGLi 432 can be used in the research of chronic inflammation, blood-brain barrier dysfunction, neurological disorders such as multiple sclerosis, Alzheimers disease and Parkinsons disease[1].
Molecular Weight:
463.80
CAS Number:
[2361575-20-2]
Formula:
C22H24BrClN2O2
Target:
MAGL
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
